Twelve weeks CLA supplementation decreases the hip circumference in overweight and obese women. A double-blind, randomized, placebo-controlled trial.

Acta scientiarum polonorum. Technologia alimentaria
Mar 2016
Citations:17
Influential Citations:2
Interventional (Human) Studies
84
S2 IconPDF Icon

Enhanced Details

Methods
Double-blind, randomized, placebo-controlled trial; overweight/obese adult women (BMI 28–42 kg/m^2; age ≥18) recruited at Poznan University of Medical Sciences, Poland (July 2014–May 2015).
Intervention
Conjugated linoleic acid (3 g/day), 12 weeks, taken as 2 capsules three times daily with meals.
Results
CLA did not reduce body weight, BMI, or waist circumference after 12 weeks. It significantly reduced hip circumference versus placebo (p=0.016209); 27/32 CLA participants vs 14/30 placebo participants showed hip circumference reduction (84.4% vs 46.7%; p=0.0017; NNT=2.65). This suggests a localized hip fat reduction and potential as a dietary supplement, though not a general weight-loss agent. Larger, longer-term randomized trials are needed.
Limitations
Small sample size and short duration; 62 of 74 randomized completed the study; dropouts may bias results; findings limited to overweight/obese women; adherence to diet and supplement not exhaustively controlled.

Abstract

BACKGROUND Conjugated linoleic acid (CLA) reduces body weight (BW), body fat mass (BFM), and increases or maintains lean body mass in animals. However, the results concerning the effect of CLA on weight reduction in humans are contradictory. The pres...